Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future.

REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche

Evusheld (cilgavimab/tixagevimab) - AstraZeneca

bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases

Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases

http://www.ncbi.nlm.nih.gov/pubmed/39995815

David A Van Eijndhoven; Robin Vos; Saskia Bos

Feb 25, 2025